The airway inflammatory response in allergic mice is downregulated by budesonide Source: Eur Respir J 2001; 18: Suppl. 33, 265s Year: 2001
Bronchial vascular remodeling is attenuated by anti-IL17 in asthmatic responses exacerbated by LPS Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019
Analysis of airway inflammation in allergic subjects with asymptomatic increased airway response to methacholine Source: Eur Respir J 2006; 28: Suppl. 50, 678s Year: 2006
Markers of inflammation and airway responses to allergen in asthmatic patients Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008
Correlation between the asthma control, bronchial inflammation and airway response to hypoosmotic stimulus Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019
Airway allergy in pregnant mice: reduced Th2 responses but enhanced airway hyperresponsiveness Source: Eur Respir J 2006; 28: Suppl. 50, 590s Year: 2006
Evidence for secretion of IL-18 in asthmatic airway inflammation assessed by endobronchial allergen challenge and its relationship to accumulation of inflammatory cells Source: Eur Respir J 2001; 18: Suppl. 33, 531s Year: 2001
Imiquimod attenuate airway inflammation and decrease the expression of TARC in allergic asthmatic mice Source: Eur Respir J 2006; 28: Suppl. 50, 224s Year: 2006
VIP knockout mice show asthma-like airway hyper-reactivity, and inflammatory response to immunologic challenge Source: Eur Respir J 2004; 24: Suppl. 48, 658s Year: 2004
The inflammation and the airway hyperresponsiveness in allergic asthma is inhibited by IL-10 dependent mechanism Source: Annual Congress 2007 - Mouse models of allergic airway inflammation Year: 2007
The effects of capsaicin on airway inflammation in asthma patients Source: Eur Respir J 2004; 24: Suppl. 48, 586s Year: 2004
Baseline airway inflammation may be a determinant of ozone response in asthmatic patients Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease Year: 2012
Inhaled IL-4/IL-13 antagonist decreases response to antigen challenge in atopic asthmatic subjects Source: Eur Respir J 2007; 30: Suppl. 51, 490s Year: 2007
Assessment of bronchial hyperreactivity, maximal airway response and response to inhaled corticosteriod treatment in patients with bronchiectasis Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007
Dose-dependent differences of allergic challenge in airway reactivity and BAL cell response Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008
IPL576,092 reduces allergen-induced late asthmatic responses, sputum eosinophilia and airway hyperresponsiveness in mild asthma Source: Eur Respir J 2003; 22: Suppl. 45, 104s Year: 2003
Correlation of bronchial inflammation pattern and airway response to cold stimulus in patients with uncontrolled asthma Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020
Markers of airway inflammation and airway hyperresponsiveness remain stable in untreated asthmatics over time Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011
Dissociation of the effects of a steroid on inflammation compared to airway hyperresponsiveness (AHR) in a model of asthma in conscious mice Source: Eur Respir J 2001; 18: Suppl. 33, 30s Year: 2001
A role for Th1 cells in airway remodeling and hyperreactivity in mice subjected to chronic allergen exposure Source: Eur Respir J 2007; 30: Suppl. 51, 734s Year: 2007